Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologics in severe asthma: the overlap endotype - opportunities and challenges.

Expert opinion on biological therapy - 1 Dec 2020

Bakakos A, Loukides S, Usmani O S, Bakakos P

Abstract excerpt

INTRODUCTION: Patients with severe asthma experience a significant burden of symptoms, disease exacerbations and medication side-effects. Severe asthma interferes with the patients' quality of life and has high health-care costs. New targeted biologic therapies have improved the management of severe asthma by significantly reducing exacerbations and maintenance corticosteroid use, and also improving lung function...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asthma

Share to Biological Products

Share to Disease Progression

Share to Phenotype

Share to Quality of Life

Share to Severity of Illness Index

Source

Identifiers

PMID: 32779950
DOI: 10.1080/14712598.2020.1809651

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologics in severe asthma: the overlap endotype - opportunities and challenges.PMID 32779950Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

Controversies and opportunities in severe asthma.Semantic proximity Read ↗

Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted ApproachSemantic proximity Read ↗

Characteristics, phenotypes, mechanisms and management of severe asthma.Semantic proximity Read ↗

Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Semantic proximity Read ↗

Moving toward consensus on diagnosis and management of severe asthma in adults.Semantic proximity Read ↗

EAACI Biologicals Guidelines-Recommendations for severe asthma.Semantic proximity Read ↗

Biologic Therapy and Novel Molecular Targets of Severe Asthma.Semantic proximity Read ↗

Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.Semantic proximity Read ↗

Severe asthma in adults: an orphan disease?Semantic proximity Read ↗

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.Semantic proximity Read ↗

Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.